表紙
市場調查報告書
商品編碼
1029577

栓塞療法的全球市場分析

Global Embolotherapy Market

出版日期: | 出版商: BCC Research | 英文 98 Pages | 訂單完成後即時交付

價格
  • 全貌
  • 簡介
  • 目錄
簡介

全球栓塞療法的市場規模在預測期間內預計以6.7%的年複合成長率發展,從2021年的31億美元,成長到2026年43億美元的規模。

各地區中,北美地區在期間中預計以7.9%發展,從2021年的11億美元,成長到2026年16億美元的規模。還有歐洲地區預計以7.1%的年複合成長率發展,從2021年的9億2370萬美元,成長到2026年13億美元的規模。

本報告提供全球栓塞療法的市場調查,栓塞療法概要,新型冠狀病毒感染疾病 (COVID-19) 以及其他的市場影響因素分析,市場規模的變化、預測,各產品、適應症、治療、終端用戶、地區的明細,競爭環境,主要企業簡介等彙整資訊。

目錄

第1章 簡介

第2章 摘要、亮點

第3章 栓塞療法概要

  • 栓塞劑的種類
  • 栓塞療法的發展的過程
  • 栓塞術的優點
  • 栓塞的風險

第4章 市場動態

  • 市場推動要素
  • 阻礙市場要素

第5章 市場分析、預測:各產品類型

  • 概要
  • 市場分析
  • 市場規模
  • 市場佔有率

第6章 市場分析、預測:各適應症

  • 概要
  • 市場分析
  • 市場佔有率

第7章 市場分析、預測:各治療

  • 概要
  • 市場分析
  • 市場佔有率

第8章 市場分析、預測:各終端用戶

  • 概要
  • 市場分析
  • 市場佔有率

第9章 市場分析、預測:各地區

  • 北美
  • 歐洲
  • 亞太地區
  • 其他地區

第10章 競爭情形

  • M&A
  • 主要的展開
  • 企業佔有率分析
  • COVID-19的影響

第11章 企業簡介

  • ACANDIS GMBH
  • ABK BIOMEDICAL
  • BALT USA LLC
  • BOSTON SCIENTIFIC CORP.
  • COOK MEDICAL
  • GUERBET
  • JOHNSON & JOHNSON
  • KANEKA CORP.
  • MEDTRONIC PLC
  • MERIT MEDICAL SYSTEMS INC.
  • PENUMBRA INC.
  • SIRTEX MEDICAL INC.
  • STRYKER CORP.
  • TERUMO CORP.
目錄
Product Code: MDS055A

Highlights:

The global market for embolotherapy should grow from $3.1 billion in 2021 to $4.3 billion by 2026 with a compound annual growth rate (CAGR) of 6.7% for the period of 2021-2026.

North American embolotherapy market should grow from $1.1 billion in 2021 to $1.6 billion by 2026 with a compound annual growth rate (CAGR) of 7.9% for the period of 2021-2026.

European embolotherapy market should grow from $923.7 million in 2021 to $1.3 billion by 2026 with a compound annual growth rate (CAGR) of 7.1% for the period of 2021-2026.

Report Scope:

This report will focus on both embolic agents and support devices. These embolization devices are used across various indications such as in oncology, nephrology, neurology, urology and vascular diseases. The report also portrays the trends and dynamics affecting the market. The report also covers market projections to 2026, and it features company profiles. By geography, the market has been segmented into the following regions: North America, Europe, Asia-Pacific and Rest of the World. For market estimates, data has been provided for 2019 as the historic year, 2020 as the base year and 2021 as the estimation year; and market forecasts have been given for 2026.

Report Includes:

  • 31 data tables and 16 additional tables
  • An overview of the global embolotherapy market with focus on both embolic agents and support devices
  • Estimation of the market size and analyses of global market trends, with data from 2019, 2020, estimates for 2021, with projections of compound annual growth rates (CAGRs) through 2026
  • Highlights of the market potential for embolotherapy, by type, indication, procedure, end user, and region
  • Detailed description of types, history, benefits, and risks associated with embolization and coverage of relationship between minimally invasive procedures and embolotherapy
  • Identification of market drivers, restraints and other forces impacting the market and analysis of the regulatory framework and product recalls of the industry
  • Market share analysis of the key companies of the industry and coverage of their proprietary technologies, strategic alliances, and other key market strategies and a relevant patent analysis
  • Comprehensive company profiles of the leading players of the industry, including Boston Scientific Corp., Johnson & Johnson, Medtronic Plc., Penumbra, Stryker Corp. and Terumo Corp.

Table of Contents

Chapter 1 Introduction

  • Introduction
  • Study Goals and Objectives
  • Scope of Report
  • Information Sources
  • Primary Research
  • Secondary Research
  • Research Methodology
  • Geographic Breakdown
  • Analyst's Credentials
  • BCC Custom Research
  • Related BCC Research Reports

Chapter 2 Summary and Highlights

Chapter 3 Overview of Embolotherapy

  • Overview
  • Types of Embolic Agents
  • Permanent Agents
  • Temporary Agents
  • History of Embolotherapy
  • Benefits of Embolization
  • Risks of Embolization

Chapter 4 Market Dynamics

  • Market Drivers
  • Increasing Demand for Minimally Invasive Procedures
  • Technological Advancements
  • Increasing Prevalence of Target Indications
  • Market Restraints
  • Lack of Skilled Interventional Radiologists
  • Complications Associated with Embolotherapy
  • Lack of Awareness
  • Market Recalls

Chapter 5 Market Breakdown by Product Type

  • Overview
  • Market Analysis
  • Global Market for Embolotherapy by Product Type
  • Global Market Shares of Embolotherapy by Product Type

Chapter 6 Market Breakdown by Indication

  • Overview
  • Market Analysis
  • Global Market Shares of Embolotherapy by Indication

Chapter 7 Market Breakdown by Procedure

  • Overview
  • Market Analysis
  • Global Market Shares of Embolotherapy by Procedure Type

Chapter 8 Market Breakdown by End-User

  • Overview
  • Market Analysis
  • Global Market Shares of Embolotherapy by End User Type

Chapter 9 Market Breakdown by Region

  • Overview
  • Global Market for Embolotherapy by Region
  • North American Market for Embolotherapy
  • North American Market for Embolotherapy by Product Type
  • North American Market for Embolotherapy by Indication
  • North American Market for Embolotherapy by Procedure Type
  • North American Market for Embolotherapy by End User
  • European Market for Embolotherapy
  • European Market for Embolotherapy by Product Type
  • European Market for Embolotherapy by Indication
  • European Market for Embolotherapy by Procedure Type
  • European Market for Embolotherapy by End User
  • Asia-Pacific (APAC) Market for Embolotherapy
  • APAC Market for Embolotherapy by Product Type
  • APAC Market for Embolotherapy by Indication
  • APAC Market for Embolotherapy by Procedure Type
  • APAC Market for Embolotherapy by End User
  • Rest of the World (RoW) Market for Embolotherapy
  • RoW Market for Embolotherapy by Product Type
  • RoW Market for Embolotherapy by Indication
  • RoW Market for Embolotherapy by Procedure Type
  • RoW Market for Embolotherapy by End User

Chapter 10 Competitive Landscape

  • Mergers and Acquisitions
  • Key Developments
  • Global Company Share Analysis
  • Impact of COVID-19 on the Embolotherapy Market

Chapter 11 Company Profiles

  • ACANDIS GMBH
  • ABK BIOMEDICAL
  • BALT USA LLC
  • BOSTON SCIENTIFIC CORP.
  • COOK MEDICAL
  • GUERBET
  • JOHNSON & JOHNSON
  • KANEKA CORP.
  • MEDTRONIC PLC
  • MERIT MEDICAL SYSTEMS INC.
  • PENUMBRA INC.
  • SIRTEX MEDICAL INC.
  • STRYKER CORP.
  • TERUMO CORP.

List of Tables

  • Summary Table A : Global Market for Embolotherapy, Through 2026
  • Summary Table B : Global Market for Embolotherapy, by Region, Through 2026
  • Table 1 : Embolization Device Recalled by FDA, 2019 and 2020
  • Table 2 : Global Market for Embolotherapy, Through 2026
  • Table 3 : Global Market for Embolotherapy, by Product Type, Through 2026
  • Table 4 : Global Market for Embolotherapy, by Indication, Through 2026
  • Table 5 : Global Market for Embolotherapy, by Procedure Type, Through 2026
  • Table 6 : Global Market for Embolotherapy, by End User, Through 2026
  • Table 7 : Global Market for Embolotherapy, by Region, Through 2026
  • Table 8 : North American Market for Embolotherapy, by Product Type, Through 2026
  • Table 9 : North American Market for Embolotherapy, by Indication, Through 2026
  • Table 10 : North American Market for Embolotherapy, by Procedure Type, Through 2026
  • Table 11 : North American Market for Embolotherapy, by End User, Through 2026
  • Table 12 : European Market for Embolotherapy, by Product Type, Through 2026
  • Table 13 : European Market for Embolotherapy, by Indication, Through 2026
  • Table 14 : European Market for Embolotherapy, by Procedure Type, Through 2026
  • Table 15 : European Market for Embolotherapy, by End User, Through 2026
  • Table 16 : APAC Market for Embolotherapy, by Product Type, Through 2026
  • Table 17 : APAC Market for Embolotherapy, by Indication, Through 2026
  • Table 18 : APAC Market for Embolotherapy, by Procedure Type, Through 2026
  • Table 19 : APAC Market for Embolotherapy, by End User, Through 2026
  • Table 20 : RoW Market for Embolotherapy, by Product Type, Through 2026
  • Table 21 : RoW Market for Embolotherapy, by Indication, Through 2026
  • Table 22 : RoW Market for Embolotherapy, by Procedure Type, Through 2026
  • Table 23 : RoW Market for Embolotherapy, by End User, Through 2026
  • Table 24 : Boston Scientific Corp.: Business Segments
  • Table 25 : Boston Scientific Corp.: Product Portfolio
  • Table 26 : Boston Scientific Corp.: Financial Performance, 2016-2020
  • Table 27 : Cook Medical: Business Segments
  • Table 28 : Cook Medical: Product Portfolio
  • Table 29 : Johnson & Johnson: Business Segments
  • Table 30 : Johnson & Johnson: Product Portfolio
  • Table 31 : Johnson & Johnson: Financial Performance, 2018-2020
  • Table 32 : Medtronic Plc: Business Segments
  • Table 33 : Medtronic Plc: Product Portfolio
  • Table 34 : Medtronic Plc: Financial Performance, 2018-2020
  • Table 35 : Merit Medical Systems Inc.: Business Segments
  • Table 36 : Merit Medical Systems Inc.: Product Portfolio
  • Table 37 : Merit Medical Systems Inc.: Financial Performance, 2016-2020
  • Table 38 : Penumbra Inc: Business Segments
  • Table 39 : Penumbra Inc.: Product Portfolio
  • Table 40 : Penumbra: Financial Performance, 2018-2020
  • Table 41 : Stryker Corp.: Business Segments
  • Table 42 : Stryker Corp.: Product Portfolio
  • Table 43 : Stryker Corp.: Financial Performance, 2016-2020
  • Table 44 : Terumo Corp.: Business Segments
  • Table 45 : Terumo Corp.: Financial Performance, 2015-2019

List of Figures

  • Summary Figure A : Global Market for Embolotherapy, 2019-2026
  • Summary Figure B : Global Market for Embolotherapy, 2019-2026
  • Figure 1 : Types of Embolic Agents
  • Figure 2 : Global Market for Embolotherapy, 2019-2026
  • Figure 3 : Global Market for Embolotherapy, by Product Type, 2019-2026
  • Figure 4 : Global Market Shares of Embolotherapy, by Product Type, 2020
  • Figure 5 : Global Market for Embolotherapy, by Indication, 2019-2026
  • Figure 6 : Global Market Shares of Embolotherapy, by Indication, 2020
  • Figure 7 : Global Market for Embolotherapy, by Procedure Type, 2019-2026
  • Figure 8 : Global Market Shares of Embolotherapy, by Procedure Type, 2020
  • Figure 9 : Global Market for Embolotherapy, by End User, 2019-2026
  • Figure 10 : Global Market Shares of Embolotherapy, by End User, 2020
  • Figure 11 : Global Market for Embolotherapy, by Region, 2019-2026
  • Figure 12 : Global Market Shares of Embolotherapy, by Region, 2020
  • Figure 13 : North American Market for Embolotherapy, by Product Type, 2019-2026
  • Figure 14 : North American Market for Embolotherapy, by Indication, 2019-2026
  • Figure 15 : North American Market for Embolotherapy, by Procedure Type, 2019-2026
  • Figure 16 : North American Market for Embolotherapy, by End User, 2019-2026
  • Figure 17 : European Market for Embolotherapy, by Product Type, 2019-2026
  • Figure 18 : European Market for Embolotherapy, by Indication, 2019-2026
  • Figure 19 : European Market for Embolotherapy, by Procedure Type, 2019-2026
  • Figure 20 : European Market for Embolotherapy, by End User, 2019-2026
  • Figure 21 : APAC Market for Embolotherapy, by Product Type, 2019-2026
  • Figure 22 : APAC Market for Embolotherapy, by Indication, 2019-2026
  • Figure 23 : APAC Market for Embolotherapy, by Procedure Type, 2019-2026
  • Figure 24 : APAC Market for Embolotherapy, by End User, 2019-2026
  • Figure 25 : APAC Market for Embolotherapy, by End User, 2019-2026
  • Figure 26 : RoW Market for Embolotherapy, by Product Type, 2019-2026
  • Figure 27 : RoW Market for Embolotherapy, by Procedure Type, 2019-2026
  • Figure 28 : RoW Market for Embolotherapy, by End User, 2019-2026
  • Figure 29 : Global Company Market Shares of Embolotherapy, 2020
  • Figure 30 : Boston Scientific Corp.: Total Sales Share, by Business Segment, 2020
  • Figure 31 : Boston Scientific Corp.: Total Revenue Share, by Region, 2020
  • Figure 32 : Johnson & Johnson: Total Sales Share, by Business Segment, 2020
  • Figure 33 : Johnson & Johnson: Total Revenue Share, by Region, 2020
  • Figure 34 : Medtronic Plc: Total Sales Share, by Business Segment, 2020
  • Figure 35 : Medtronic Plc: Total Revenue Share, by Region, 2020
  • Figure 36 : Merit Medical Systems Inc.: Total Sales Share, by Business Segment, 2020
  • Figure 37 : Merit Medical Systems Inc.: Total Revenue Share, by Region, 2020
  • Figure 38 : Penumbra: Total Sales Share, by Business Segment, 2020
  • Figure 39 : Penumbra: Total Revenue Share, by Region, 2020
  • Figure 40 : Stryker Corp.: Total Sales Share, by Business Segment, 2020
  • Figure 41 : Stryker Corp.: Total Revenue Share, by Region, 2020
  • Figure 42 : Terumo Corp.: Total Sales Share, by Business Segment, 2019
  • Figure 43 : Terumo Corp.: Total Revenue Share, by Region, 2019